Inovio highlights anticipated 2025 milestones and 2024 key accomplishments

Plymouth meeting, pa. , jan. 9, 2025 /prnewswire/ -- inovio (nasdaq: ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today highlighted anticipated milestones for 2025 and key accomplishments from 2024 in advance of upcoming investor meetings.
INO Ratings Summary
INO Quant Ranking